Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine

In Japan, a bivalent human papillomavirus (HPV) vaccine against carcinogenic HPV16/18 was licensed in 2009, and a quadrivalent vaccines against HPV16/18 and non-carcinogenic HPV6/11 was licensed in 2011. Recently, the next-generation 9-valent vaccine targeting HPV6/11/16/18/31/33/45/52/58 has been a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Tohoku Journal of Experimental Medicine 2020, Vol.251(4), pp.287-294
Hauptverfasser:	Kukimoto, Iwao, Matsumoto, Koji, Takahashi, Fumiaki, Iwata, Takashi, Tanaka, Kohsei, Yamaguchi-Naka, Mayuko, Yamamoto, Kasumi, Yahata, Hideaki, Nakabayashi, Makoto, Kato, Hisamori, Tsuda, Naotake, Onuki, Mamiko, Yaegashi, Nobuo, Group, MINT Study II
Format:	Artikel
Sprache:	eng
Schlagworte:	cervical cancer cervical intraepithelial neoplasia genotyping human papillomavirus vaccine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!